USPTO serial 79364905
SINGLERA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 2, 2024
- Examiner
- HOWARD, PARKER WALDRIP
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with SINGLERA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Timothy T. Wang
Timothy T. Wang NI, WANG & MASSAND, PLLC8140 WALNUT HILL LN, SUITE 615DALLAS, TX 75231UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Preparations of microorganisms for scientific research purposes, other than for medical and veterinary use; proteins for the food industry; stem cells for scientific research purposes, other than for medical or veterinary purposes; chemical preparations for scientific purposes, other than for medical or veterinary use; vitamins for use in the manufacture of pharmaceuticals; adhesive preparations for use in the manufacture of surgical bandages; preservatives for pharmaceutical preparations; biological preparations for scientific purposes, other than for medical or veterinary purposes; vitamins for the food industry; antioxidants for use in the manufacture of pharmaceuticals | ACTIVE | — |
| 005 | Medicines for human purposes, namely, medicines for gene therapy and cancer diseases; pharmaceutical preparations for the treatment of gene and cancer diseases; diagnostic preparations for medical purposes; biological preparations for the treatment of gene therapy, cancer and genetic testing; Chemical preparations for the treatment of gene therapy, cancer and genetic testing; depuratives for the body; diagnostic preparations for veterinary purposes; pesticides; dressings, medical | ACTIVE | — |
| 037 | Installation and repair of medical equipment; installation and repair of sanitation facilities; installation, maintenance and repair of computer hardware; machinery installation, maintenance and repair; Disinfecting in the nature of disinfecting medical instruments; sterilization of medical instruments; surgical equipment disinfection; Repair information regarding medical machines and apparatus; Building construction; upholstering | ACTIVE | — |
| 040 | Material treatment information; food and drink preservation; stripping finishes; recycling of waste and trash; air purification; water treating; medicinal materials processing; processing of chemical reagents; millworking; cryopreservation services | ACTIVE | — |
| 041 | Medical training and teaching; Educational services, namely, conducting seminars, conferences, workshops in the field of medical and science; Arranging and conducting of symposiums in the field of medical and science; training services, namely, arranging and conducting workshops in the field of medical and science; mobile library services; publication of texts, other than publicity texts; Providing on-line electronic publication, not downloadable, in the nature of e-books, e-magazines, brochures and newsletters in the field of science and medical; Providing online videos, not downloadable, featuring science and medical; party planning; conducting fitness classes | ACTIVE | — |
| 042 | Technical research in the field of cancer disease, gene expression, genetic testing, gene therapy, gene editing technology and related medicines; Scientific research in the nature of conducting clinical trials in the field of cancer disease, gene expression, genetic testing, gene therapy, gene editing technology and related medicines; biological research; bacteriological research; Cloud computing featuring software for medical purposes; industrial design; conducting technical project studies for construction projects; creating and maintaining web sites for others; chemical analysis; material testing | ACTIVE | — |
| 044 | Medical clinic services; medical assistance; advisory services relating to health; telemedicine services; medical equipment rental; hospital services; rental of sanitary installations; beauty salon; dietary and nutritional guidance; sanatorium services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by SINGLERA GENOMICS (CHINA) LTD.
- Other trademarks owned by SINGLERA GENOMICS (CHINA) LTD.
- Other trademarks owned by SINGLERA GENOMICS (CHINA) LTD.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 037
- Other trademarks in Class 040
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named SINGLERA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 30, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 18, 2024 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Oct 18, 2024 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Jul 3, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 2, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Apr 2, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 16, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 16, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 13, 2024 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 27, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 27, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Dec 27, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 12, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 7, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 7, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 7, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 5, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 23, 2023 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jun 11, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 11, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 29, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 28, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 25, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 17, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 13, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 9, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |